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Abstract
Background:  p63 is a transcription factor that plays an important role in skin epidermal
development and differentiation. The p63 gene encodes for two major protein isoforms, those
containing an amino-terminal trans-activation domain (TAp63) and those lacking this domain
(ΔNp63). Both the TA and ΔN transcripts are also alternatively spliced at the 3' end producing
proteins with unique C-termini that are designated as α, β and γ isoforms. Recent research has
suggested that ΔNp63 is the predominant isoform expressed and active in keratinocytes.
Results:  To better elucidate the biological role of p63 in regulating gene expression in
keratinocytes we performed chromatin immunoprecipitation (ChIP) experiments with ΔNp63-
specific antibodies. We included an additional step in the ChIP procedure to enrich for ΔNp63
targets by screening the library of immunoprecipitated DNA for its ability to bind recombinant
GST-ΔNp63. Cloning of ΔNp63-ChIP-derived DNA fragments identified more than 60 potential
ΔNp63 target loci that were located close to or embedded within known or predicted genes.
Identity of these target genes suggests that they may participate in a myriad of cellular processes
including transcriptional regulation, signaling and metabolism. Here we confirm the binding of
ΔNp63 to several of these genomic loci both by EMSA and replicate ChIP assays. Finally we show
that the expression of many of these target genes is altered when ΔNp63 levels in keratinocytes
are reduced by siRNA, further confirming that these are bona fide targets.
Conclusion: This unbiased genomic approach has allowed us to uncover functional targets of
ΔNp63 and serves as the initial step in further analysis of the transcriptional regulatory mechanisms
that are governed by p63 in keratinocytes.
Background
The transcription factor p63, which belongs to a family of
genes that also include p53 and p73, plays an important
role in the transcriptional regulation of many biological
processes including development, differentiation and
apoptosis[1,2]. Interestingly, p63 exhibits a restricted spa-
tio-temporal expression pattern with high levels reported
in epithelial cells. Indeed, the function of p63 has been
predominantly examined in stratified epithelium in many
organs such as the skin, mammary glands, prostate etc.
Both gain-of-function and loss-of-function studies have
clearly demonstrated that p63 is a critical master regulator
of the epithelial differentiation program[1,3]. This is quite
evident in the dramatic phenotype of the p63 knockout
mice, which lack stratified epithelium and their deriva-
tives in multiple tissues and organs[4,5].
Published: 23 May 2007
BMC Molecular Biology 2007, 8:43 doi:10.1186/1471-2199-8-43
Received: 19 February 2007
Accepted: 23 May 2007
This article is available from: http://www.biomedcentral.com/1471-2199/8/43
© 2007 Birkaya et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
Page 2 of 15
(page number not for citation purposes)
The biological function of p63 is mediated by several iso-
forms derived from distinct transcripts that are generated
from a complex genomic structure. The p63 gene gives rise
to two major transcript variants through the use of distinct
promoters, which are located far apart from each other[6].
The proximal promoter located upstream of exon1 directs
the expression of transcripts that encode for an amino ter-
minal transactivation domain (TA), whereas an internal
promoter embedded within the third intron controls the
expression of transcripts that lack this domain (ΔN). In
addition, both the TA and ΔN transcripts are differentially
spliced at the 3' end to generate proteins with unique C-
termini that are designated as α, β and γ isoforms of p63.
All isoforms of p63 share a DNA-binding and an oli-
gomerization domain, which shows sequence conserva-
tion with p53. Hence, these proteins are capable of
sequence specific DNA-binding to p53 response elements
and related sequences. Although the ΔNp63 isoforms
were initially thought to function by exerting dominant
negative effects on TAp63, it is increasingly becoming
clear that the ΔNp63 proteins also mediate direct tran-
scriptional activation and repressor activities on target
genes [7-10]. In view of the fact that there are high levels
of ΔNp63 protein but not TAp63 in many epithelial cells
and that the ΔNp63 isoform is the only form of p63
present in lower organisms, it is thought that ΔNp63 may
be the primary mediator of the biological function of the
p63 gene.
Since p63 is a transcription factor, it is likely that it gov-
erns the various cellular processes and developmental
decisions by regulating specific target genes. Although p63
has been shown to regulate some well-characterized p53
responsive genes, it is becoming increasingly evident that
there exists a unique set of p63 target genes[11]. This
notion is further strengthened by the fact that p63 has a
distinct functional role in development and that the DNA-
binding activity of these two proteins exhibits clear differ-
ences[1,12,13]. It is also possible that both p53 and p63
can regulate common target genes as exemplified by
maspin, IGFBP-3 and PERP, which though initially were
thought to be regulated by p53 are now clearly proven to
also be p63 targets [14-17]. To identify additional p63 tar-
gets, some laboratories have utilized an experimental
model system where cells lacking p63, such as Saos2 or
HEK 293, were assessed for global alterations in gene
expression by microarray analysis under conditions where
p63 is over expressed[12,18,19]. Although these and sim-
ilar other studies have unearthed some interesting poten-
tial p63 targets, identifying the exact location of the cis-
elements that mediate the transcriptional effects of p63
have remained elusive[20]. Hence, a direct examination
of p63-responsive elements in epithelial cells, which
express high levels of p63 under physiological conditions,
is warranted.
Keratinocytes express high levels of ΔNp63 and have pro-
vided a useful model system to dissect the role of p63 and
to study its target genes[10]. These studies have been facil-
itated by chromatin immunoprecipitation (ChIP) experi-
ments to confirm known p63 binding sites within the
promoters of selected downstream targets in vivo.
Although ChIP can be also a powerful tool to identify pre-
viously unknown targets of transcription factors, technical
limitations have often precluded such an experimental
strategy. In this paper, we report our initial results with an
improved genomic ChIP approach to isolate and charac-
terize 62 potential genomic ΔNp63 binding sites in kerat-
inocytes. These sites are associated with various genes
involved in a wide variety of cellular processes including
transcription, signaling and metabolism. As proof of prin-
ciple we have confirmed the association of ΔNp63 with a
subset of these targets both in vitro and in vivo. Finally, we
demonstrate that the expression levels of the potential
ΔNp63 target genes located close to these genomic bind-
ing locations are affected when p63 levels are lowered.
Collectively, our studies highlight the robustness of our
experimental strategy to unearth novel targets for ΔNp63
and thus can be extended to other transcription factors.
Results
A modified ChIP strategy for enrichment and cloning of 
ΔNp63-target elements
To better understand the mechanisms by which ΔNp63
transcriptionally regulates the keratinocyte development
and differentiation program we sought to identify its in
vivo target genes by a ChIP strategy. For this purpose we
utilized HaCaT cells, which are immortalized human
keratinocytes that have been widely used to study kerati-
nocyte biology. These cells express high levels of ΔNp63,
which can be detected by an isoform-specific antibody
RR-14 that has been generated by our laboratory and has
been successfully used in ChIP experiments[21]. ChIP
strategy is widely utilized to examine if a specific genomic
site is occupied by a transcription factor in the context of
a living cell. However, identification of unknown targets
by cloning and sequencing the DNA that is obtained from
the immunoprecipitated material has proven to be techni-
cally challenging. This is mostly due to limiting amounts
of DNA obtained during the procedure and overwhelm-
ing excess of non-specifically precipitated DNA. To over-
come these issues, we incorporated two additional steps
in our experimental scheme to improve the efficiency of
obtaining ΔNp63 targets. First we utilized a ligation-medi-
ated PCR technique, during which the ChIP products
obtained after immmunoprecipitation were ligated to
linkers and amplified by PCR using the linker sequence
for priming[22]. This allowed us to obtain sufficient mate-BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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rial for subsequent purification and cloning (Figure 1).
Second, to reduce the contamination with non-specific
DNA fragments, we purified the PCR-amplified fragments
by incubation with agarose beads containing GST-
ΔNp63α protein. This enrichment procedure allowed us
to select for DNA fragments that are more likely to contain
binding-sites for ΔNp63. The DNA fragments obtained
from chromatin immunoprecipitation were then digested
with restriction enzyme (present in the linker) and cloned
into pBluescript vector as described in Materials and
Methods. We isolated and sequenced 113 individual
clones that represented the DNA fragments immunopre-
cipitated by ΔNp63.
The location and identity of the ΔNp63 target genomic 
DNA fragments obtained after ChIP cloning
We searched the human genomic database by BLAST to
determine the location of the immunoprecipitated DNA
fragments in relation to known or predicted genes. This
analysis revealed that 62 of the extracted DNA fragments
immunoprecipitated by ΔNp63 mapped in proximity to
known, annotated or predicted genes (those supported by
mRNA sequences, or predicted by expressed sequence
tags, EST). We used the following criteria to assign the
DNA fragments to a specific gene: if the sequence matched
a) to the intragenic region of a known or predicted gene or
b) to a region within 100 kb upstream or downstream of
a gene. Tables 1, 2, 3 list the genomic distribution of the
62 gene-associated ΔNp63 binding fragments. The
remaining ChIP fragments that were obtained from
sequencing were not analyzed further since they either
corresponded to non-annotated regions of the human
genome or no mRNA or EST sequence that would predict
a gene was found within a 100 kb distance of the DNA
fragment. It is possible that some of these genomic
sequences may represent distal enhancers involved in reg-
ulating gene expression from distances significantly far-
ther than 100 kb as has been demonstrated for many
enhancers. Alternatively, these segments may denote non-
annotated regions of the genome that do not encode for
conventional genes but are sites for miRNA and similar
elements. Some of these elements may also represent
experimental artifacts resulting from non-specific DNA-
binding of ΔNp63 to certain chromatin regions that are
captured during formaldehyde cross-linking or contami-
nating DNA obtained during the immunoprecipitation or
PCR enrichment steps.
Examination of the sixty-two potential ΔNp63 target
genes revealed several interesting findings. Forty percent
of the ΔNp63-ChIP fragments were located within an
intron of known or predicted genes, with a quarter of
them in the first intron (Tables 1, 2, 3 and figure 2). This
observation is in agreement with many other transcrip-
tion factors such as Myc and Sp1 for which genomic bind-
ing sites have been deciphered on a large scale and reflects
the growing evidence for the presence of intragenic cis-
regulatory regions for transcriptional control. A further
forty-four percent of the DNA fragments chromatin
immunoprecipitated by ΔNp63 were located within the
region spanning 100-kb upstream or downstream of can-
didate target genes. Although several sites were located
less than 10-kb upstream of a transcription start site, only
a small number mapped to the promoter proximal
regions. This may reflect the propensity of ΔNp63 to act
primarily through distal enhancers or simply signify
under-representation of promoter regions since they are
not well defined and properly annotated for a vast major-
ity of human genes. Interestingly, for a distinct number of
cases the sequence chromatin immunoprecipitated by
ΔNp63 corresponded to a region that was close to two
genes; for example fragment A8 mapped to a segment that
was at the 5' end of the NAPA gene but also closely located
at the 3' of ZNF541 gene (Table 3). In such situations, the
close proximity of the p63-response element to both of
these potential target genes makes it difficult to ascertain
whether either one or both of these genes are bona-fide
ΔNp63 targets without further experimental evidence.
Functional classification of these potential targets based
on Gene Ontology categorization revealed that these are
widely distributed among a wide variety of categories
including transcriptional regulation, signaling cascades
and metabolism. Of note some of the potential ΔNp63
target genes that we identified in our screen have been pre-
viously shown to be regulated by p63 (Table 1 and 3).
These data reaffirms the validity of our ChIP based clon-
ing approach and offer further evidence that some of these
previously identified targets of ΔNp63 are direct ΔNp63
transcriptional targets and more importantly identifies
the location of the ΔNp63-response elements that might
be responsible for such an effect.
Expression of a subset of ΔNp63 target genes in HaCaT 
cells and confirmation of ΔNp63 binding by independent 
ChIP assays
To facilitate further studies of the potential ΔNp63 targets,
we selected fourteen loci from the sixty initially identified
by ChIP. These DNA fragments immunoprecipitated by
ΔNp63 were arbitrarily chosen and represented different
locations relative to the target genes and genes that were
involved in a variety of cellular processes. For simplicity
we focused mostly on ΔNp63 sites that were located close
to a single gene. First we performed RT-PCR experiments
to test if these genes were indeed expressed in HaCaT cells.
As a control we used human skin. Of the fourteen candi-
dates chosen, two of them WASPIP and SYN3 showed no
detectable expression in HaCaT cells (Figure 3). It is pos-
sible that these two genes are not expressed in HaCaT cells
in the specific cell culture conditions used or that their
normal expression is repressed by p63. Alternatively,BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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A schematic representation of the modified chromatin immunoprecipitation approach used to identify potential target genes of  ΔNp63 Figure 1
A schematic representation of the modified chromatin immunoprecipitation approach used to identify poten-
tial target genes of ΔNp63. Following chromatin immunoprecipitation, to enrich for ΔNp63 targets, ChIP products were 
ligated to linkers and amplified by PCR using the linker sequence for priming. The PCR-amplified products were subsequently 
incubated with agarose beads containing GST-ΔNp63 protein. ChIPed fragments were then digested with Hind III, cloned, and 
sequenced.
∆Np63
Hind III Hind III
Hind III Hind III
Hind III Hind III
∆Np63
Crosslink HaCaT Cells
Immunoprecipitate with ΔNp63 antibody  
(RR-14)
Adaptor ligation
PCR amplification
Immobilize on GST-ΔNp63α beads
Hind III digestion and clone 
into pBluescript
Sequence 113 clones
Database search
62 potential genes identifiedBMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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expression of these genes may be restricted to the dermal
or other non-keratinocyte compartment of the skin. The
remaining twelve genes showed expression in both
HaCaT cells and in skin and were chosen for further stud-
ies. Since these twelve genes are co-expressed with ΔNp63
in HaCaT cells, we next confirmed the binding of ΔNp63
to the isolated ChIP fragments by performing independ-
ent ChIP assays (Figure 4). For these experiments, cross-
linked chromatin from HaCaT cells was immunoprecipi-
tated in independent experiments with two different anti-
p63 antibodies and the co-precipitation of the ΔNp63-
response elements was ascertained by PCR. The antibod-
ies we chose were an N-terminal specific antibody, RR-14,
which was utilized in the original genomic screen and a
commercially available anti-p63 antibody, H-129 that
recognizes the C-terminal domain of the ΔNp63α protein.
We utilized sets of primers that amplify the twelve frag-
ments immunoprecipitated by ΔNp63 and as a negative
control we used a set of primers that amplify a genomic
segment in the GAPDH gene. As shown in Figure 4A, after
immunoprecipitation of cross-linked chromatin we
found that there was specific enrichment of eleven poten-
tial  ΔNp63-response elements with both antibodies
against p63 compared to IgG control. In contrast, we did
not observe any localization of ΔNp63 to the GAPDH or
TADA3L genomic loci as demonstrated by the negative
PCR results. Similar results were obtained from three
independent ChIP experiments. The relative enrichment
of each fragment was also examined by quantitative PCR
in at least three independent ChIP experiments (Figure
4B). For this, we performed parallel ChIP assays where
either the two anti-p63 antibodies or IgG was used for
immunoprecipitation. The relative fold enrichment of
ΔNp63-ChIP fragments was determined by comparing the
amount of fragment-specific PCR product amplified from
the anti-p63 ChIP, and the negative control (IgG) ChIP
samples. For eleven of the ΔNp63-ChIP fragments exam-
ined significant enrichment was observed with anti-p63
antibody, except TADA3L and control GAPDH. This spe-
cific enrichment suggests that the DNA fragments chro-
matin immunoprecipitated from the genomic screen
represent bona fide binding sites for ΔNp63 in HaCaT cells.
Table 1: List of known genes located within 100 kb of the DNA sequences isolated after ChIP that are putative targets of p63.
p63 Binding 
Fragment
Chromosome 
Number
Nearest gene Location Description Accession 
Number
Gene Ontology
A2 3p12 SHQ1 3' end SHQ1 homolog (S. cervisiae) NM_018130 RNA processing
A4 7p15 AHR* intron 10 Aryl hydrocarbon receptor NM_001621 Transcription
A5 13q22 KLF12 intron 6 Kruppel-like factor 12 NM_0072498 Transcription
A6 11p15 ARNTL* 5'end Ayrl hydrocarbon receptor nuclear 
translocator-like
NM_001178 Transcription
B2 11cenq22 ME3 intron 1 Malic enzyme 3 NM_001014811 Oxioreductase activity
B5 12q13 STAT6* intron 19 Signal transducer and activator of 
transcription 6
NM_003153 Transcription
C3 7p15.1 ZNRF2* intron 1 Zinc and ring finger 2 NM_147128 Ubiquitin ligase activity
C6 6q22.31 HSF2* intron 10 Heat shock transcription factor 2 NM_004506 Transcription
C10 2q31-q32.1 CHN1 intron 5 Chimerin 1 NM_001025201 Signal transduction
C11 8q24.13 FBXO32* intron 4 F-box protein 32 NM_058229 Protein degradation
D2 5q21.3 PJA2* 5' end Praja2, RING-H2 motif containing NM_014819 Ubiquitin ligase
D5 5q31.3 NR3C1* intron 2 Nuclear receptor subfamily 3 NM_00176 Signal transduction
D7 Xq21.1 POF1B* 5' end Premature ovarian failure NM_024921 Cytoskeleton organization
D9 8q12.3 YTHDF3 3' end YTH domain family member 3 NM_152758 Unknown
D12 6p21.3 DDR1* intron 3 Discoidin domain receptor, family member 1 NM_013993 Cell adhesion
E2 10p12.1 GPR158* intron 4 G-protein coupled receptor 158 NM_020752 Signal transduction
E6 5q31.1 SLC22A4 intron 1 Solute carrier family 22, member 4 NM_003059 Transport
E12 9q13 B4GALT1* intron 1 UDP-Gal:betaGLCNAc beta 1,4-
galtosyltransferase
NM_001497 Carbohydrate metabolism
G9 12q24.31 AACS 3'end Acetoacetyl-CoA synthetase NM_145248 Metabolism
H3 2q21.1 WASPIP* intron 2 Wiskott-Aldrich syndrome protein 
interacting protein
NM_003387 Cytoskeleton organization
H4 15q21.2 SPPL2A 5' end Signal peptide peptidase-like 2A NM_032802 Protein degradation
H6 7p15-p14 TBX20 5' end T-Box 20 NM_020417 Transcription
H8 12q13 SLC38A4 5' end Solute carrier family 38, member 4 NM_018018 Transport
H12 3q27 MCCC1 intron 10 Methylcrotonoyl-Coenzyme A caboylase 1 NM_020166 Metabolism
I5 22q12.3 SYN3* intron 6 Synapsin 3 NM_003490 Neurotransmitter secretion
J1 7p12-p11.2 GRB10 intron 3 Growth factor receptor-bound protein 10 NM_00100549 Signaling
J2 1q21.2 NOTCH2NL* intron 1 Notch homolog 2 NM_203458 Signal transduction
J3 14q32.3 MARK3 intron 4 MAP-microtubule affinity regulating kinase 3 NM_002376 Kinase activity
J5 5q35.3 MXD3 intron 4 MAX dimerization protein 3 NM_031300 Transcription
J7 8q12.1 RGS20* intron 4 Regulator of G-protein 20 NM_003702 Signal transduction
E1 3q25.3 TADA3L 3' end Transcriptional adaptor 3 NM_006354 Transcription
Shown are known genes located closest to each p63 ChIPed DNA sequence and the corresponding chromosome number. Also shown are the 
location of the p63-binding site within each gene, NCBI accession number, and gene function.  Asterisks indicates those genes that were also 
identified by other studies.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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The fact that the TADA3L locus could not be amplified
under the replicative ChIP conditions suggests that this
may be a false positive.
Direct binding of ΔNp63 to p63-response elements located 
within the DNA fragments immunoprecipitated by ΔNp63
Of the fourteen potential ΔNp63 targets, eleven were
expressed in HaCaT cells and independent ChIP experi-
ments suggested that ΔNp63 could associate with a
genomic fragment present within or close to these genes.
Since this association of ΔNp63 to such sites could be
either direct or indirect, we analyzed the eleven DNA frag-
ments for the presence of p63 consensus DNA binding
sites. Our recent experiments have defined the optimal
p63 DNA-binding consensus motif as (T/
A)A(T)ACA(T)TGT(T/A)T consisting of a CA(T)TG core
and AT-rich 5' and 3' flanking sequences[13]. Indeed
many of the known p63 target genes contain such a p63-
response element in their regulatory regions. We found
that the eleven DNA fragments chromatin immunopre-
cipitated contained at least one stretch of sequence that
matched closely the p63-consensus, and in several cases
more than one potential p63-response element was
detected. To experimentally test these p63-like response
Table 3: ChIPed DNA sequences that correspond to two potential target genes.
p63 Binding 
Fragment
Chromosome 
Number
Nearest Gene Location Description Accession Number Gene Ontology
A8(a) 19q13.32 ZNF541 3' end Zinc finger protein 541 NM_032255 Transcription
A8(b) 19q13.32 NAPA* 5' end N-ethylmaleimide-sensitive factor protein NM_003827 Transport
B1(a) 6q23.3 FLJ46906 3' end Hypothetical gene supported by Ak128874; 
BC071813
XM_928441 Unknown
B1(b) 6q23.3 CCDC28A 5' end Coiled-coil domain containing 28A NM_015439 Unknown
B3(a) 12q22 LOC642961 3' end Hypothetical protein XM_931709 Unknown
B3(b) 12q22 MRPL42 5' end Mitochondrial ribosomal protein L42 NM_014050 Protein biosynthesis
C7(a) 20p12.1 WFDC12 NL WAP four-disulfide core domain 12 NM_080869 Protease inhibitor
C7(b) 20p12.1 LOC613266 NL Hypothetical LOC613266 ND Unknown
D6(a) 1q32.1 Clorf116* NL Chromosome 1 open reading frame 116 NM_023938 Unknown
D6(b) 1q32.1 LOC653098 5' end Similar to chromosome 1 open reading 
frame
XM_925981 Unknown
E10(a) 1p21-p13 CSF1 3' end Colony stimulating factor 1 NM_000757 Cell proliferation/differentiation
E10(b) 1p13.2 AHCYL1 5' end S-adenosyl homocystein hydrolase-like 1 NM_006621 Adenoyslhomocyteinase
G5(a) 21q22.11 LOC728598 5' end Similar to oligodendrocyte transcription 
factor 1
XM_001127883 Transcription
G5(b) 21q22.11 LOC728409 3' end Hypothetical protein XM_001128368 Unknown
G10(a) 13q34 LOC122258 5' end Hypothetical protein NM_145248 Unknown
G10(b) 13q34 LOC400163 5' end Hypothetical protein supported by 
BC034786
ND Unknown
H1(a) 6q15 CYCSP16 NL Cytochrome c, somatic pseudogene 16 NG_002966 Unknown
H1(b) 6q15 RNGTT NL RNA guanylytransferase and 5' phosphatase NM_003800 mRNA processing
H5(a) 15q24 CRABP1 3' end Cellular and retinoic acid binding protein 1 NM_004378 Signal transduction
H5(b) 15q25.1 IREB2 5' end Iron-responsive element binding protein 2 NM_004136 Metabolism
Shown are the genes located closest to each p63 ChIPed DNA sequence and the corresponding chromosome number. Also shown are the location of the p63-binding site 
within each gene, NCBI accession number, and gene function. NL, Not localized; ND, Not determined; Asterisks indicates those genes that were also identified by other 
studies.
Table 2: List of hypothetical genes that are putative target genes of p63 located within 100 kb of ChIPed DNA sequences.
p63 Binding 
Fragment
Chromosome 
Number
Nearest Gene Location Description Accession Number Gene Ontology
A12 10q22.2 C10orf11 intron 4 Chromosome 10 open reading frame 11 NM_032024 Unknown
B4 18q12.3 LOC284260 intron 7 Hypothetical protein XM_211408 Unknown
C1 15q26.1 LOC441732 NL Hypothetical LOC441732 ND Unknown
D1 4q21.22 LOC441026 NL Heterogenous nuclear ribonucleoprotein A3 
pseudogene
NG_005584 Unknown
D10 1p32.3 C1orf34 NL Chromosome 1 open reading frame 34 ND Unknown
E8 5q31.1 LOC642961 3' end Hypothetical protein XM_931289 Unknown
F9 20q11.1 LOC645487 5' end Hypothetical protein XM_932932 Unknown
G12 3q13.13 LOC440973 NL Similar to Nuclear transcription factor Y 
subunit beta
ND Unknown
H11 5q13.2 LOC644420 intron 1 Hypothetical protein XM_927568 Unknown
I2 9p11.2 FAM27E1 NL Family with sequence similarity 27 member 
E1
NM_001024608 Unknown
I4 10q23.31 LOC643529 intron 3 Hypothetical protein XM_931612 Unknown
Shown are hypothetical genes located closest to each p63 ChIPed DNA sequence and the corresponding chromosome number. Also shown are 
the location of the p63-binding site within each gene, NCBI accession number, and gene function. NL, Not localized; ND, Not determined.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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elements, we designed oligonucleotide probes (see Addi-
tional File 1 for sequences) for two of the sites from each
locus that most closely matched the p63-consensus and
performed Electrophoretic Mobility Shift Assays (EMSA).
As a control, we utilized a p63-response element from the
K14 enhancer that has been demonstrated to be a bona-
fide p63 binding site[10]. We used similar molar amounts
of each radiolabeled oligonucleotide to allow the relative
binding to each probe to be compared. EMSA showed that
recombinant ΔNp63 was capable of binding strongly to at
least one of the p63-response elements present in the
immunoprecipitated DNA fragments corresponding to all
eleven target genes (Figure 5A). For some target genes,
such as MXD3,  NR3C1  and  FBXO32  both the p63-
response elements showed similar binding strength to
ΔNp63. However, for the remaining targets only one of
the oligonucleotide probes bound to ΔNp63 suggesting
that flanking sequences likely influence the DNA-binding
specificity as shown previously by our laboratory[13].
Having shown that these oligonucleotides containing
p63-response elements can bind to recombinant ΔNp63
purified from bacteria, we wanted to test if they could also
bind to native ΔNp63 present in cells. For this purpose we
utilized nuclear extracts from HaCaT cells and repeated
EMSAs with the oligonucleotide that demonstrated the
best binding to recombinant ΔNp63 for each of the eleven
target genes. Upon incubation with labeled oligonucle-
otide, a specific complex was observed with HaCaT
nuclear extracts in each case. This complex was clearly
formed by ΔNp63, since addition of anti-p63 antibodies
resulted in a distinct supershift (Figure 5B). Taken
together our EMSA studies suggest that the fragments
immunoprecipitated contain legitimate p63-response ele-
ments that can bind to recombinant ΔNp63 and more
importantly to endogenous ΔNp63 present in keratinoc-
ytes.
Transcriptional activation of the DNA fragments 
chromatin immunoprecipitated by ΔNp63
Having shown that ΔNp63 can bind to these eleven ChI-
Ped segments both in vitro and in vivo we next examined
their responsiveness to ΔNp63 in transient transfection
experiments. For these experiments we chose PtK2 cells
since these have been shown to lack any endogenous p63
expression. First we cloned each of the eleven fragments
corresponding to the genomic regions containing p63-
response elements in a luciferase reporter plasmid
upstream of the heterologous thymidine kinase (TK) pro-
moter. Each reporter plasmid was co-transfected with
either an expression plasmid encoding for HA-tagged
ΔNp63α or an empty HA control vector. As shown in Fig-
ure 6, expression of ΔNp63α resulted in increased levels of
reporter activity (2–5 fold) for each of the eleven con-
structs compared to empty vector. These data along with
those obtained from the previous ChIP experiments and
EMSA strongly argue that ΔNp63 activates these eleven
target genes through the p63-response elements.
Inhibition of p63 in HaCaT cells affects the expression of 
ΔNp63 target genes
The fact that ΔNp63 can bind and activate the regulatory
elements associated with the target genes suggests that
ΔNp63 might be a transcriptional regulator for these
genes. Hence, to demonstrate more directly whether
ΔNp63 is involved in regulating expression of the putative
ΔNp63 target genes, we examined the effect of inhibiting
p63 expression in HaCaT cells. We used synthetic dsRNA
(siRNA) to reduce p63 expression in HaCaT cells. As
shown in Figure 7, the use of siRNA led to a significant
Expression of ΔNp63 target genes in human skin and HaCaT  cells Figure 3
Expression of ΔNp63 target genes in human skin and 
HaCaT cells. Total RNA was isolated from human skin and 
HaCaT cells and RT-PCR was performed using the primers 
listed in Additional File 3A to specifically amplify the target 
genes. β-Actin serves as a control.
B4GALT1 MARK3
FBXO32 STAT6
AHR
HSF2
β-Actin
- +
Skin
+ -
HaCaT
MXD3
YTHDF3
NR3C1
ZNRF2
NOTCH2NL
RT
WASPIP
SYN3
TADA3L
β-Actin
- +
Skin
+ -
HaCaT
RT
Location of the identified p63 ChIPed DNA sites relative to  known gene Figure 2
Location of the identified p63 ChIPed DNA sites rela-
tive to known gene. Examination of 60 potential target 
genes demonstrates that p63 binding sites are located within 
introns as well as at the 5' end and 3' end of these target 
genes.
intron 1
other introns
5' end
3' end
no localization
10%
30%
26%
18%
16%BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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reduction in the expression of p63 mRNA levels in cells
transfected with the p63 siRNA. This reduction in p63
amounts was also evident at the protein level (Additional
File 2). We performed at least three quantitative RT-PCR
assays using cDNA synthesized from three independent
RNAi experiments to examine the expression of the eleven
putative p63 target genes. The housekeeping gene B2M
(beta2 microglobulin) was used as a reference standard.
As shown in Figure 7, expression of six of these genes
NR3C1, STAT6, HSF2, AHR, YTHDF3, and FBXO32 were
dramatically reduced by more than 75% in response to
p63 siRNA. This indicates that a threshold level of p63 is
required to maintain expression of these genes. On the
other hand, three target genes ZNRF2, NOTCH2NL, and
MARK3 showed more modest reduction in mRNA levels
of approximately 50%. This relatively modest reduction in
expression of these target genes may be due to the fact that
persistent low level of p63 is sufficient to maintain their
expression. Alternatively, regulation of these target genes
may involve additional repressors and/or activators that
may compensate for the lack of p63. Interestingly, two
genes, MXD3 and B4GALT1 were modestly up regulated
when p63 levels were low, suggesting that p63 might play
a role in transcriptional repression of these two targets.
This is despite the fact that in transient transfection exper-
iments, the DNA fragments immunoprecipitated by
ΔNp63 corresponding to both MXD3 and B4GALT1 were
positively activated by ΔNp63 (Figure 6). This implies that
the transcriptional regulation process of these two poten-
tial targets in vivo is more complex and that either addi-
tional direct p63-response elements exist or indirect
effects from knockdown of p63 might influence the bal-
ance of positive and negative transcriptional regulators.
Overall, our data suggests that of the subset of genes iden-
tified by ΔNp63-ChIP and examined in this study, a large
proportion of them are likely to be genuine regulatory tar-
gets of ΔNp63 in HaCaT cells.
Discussion and conclusions
Identifying target genes is critical in understanding the
mechanism by which the transcription factor p63 regu-
lates the intricate process of epithelial development and
differentiation. Towards this end, several laboratories
have undertaken a target discovery approach that involves
manipulating the activity of p63 followed by gene expres-
sion analyses[12,18,23,24]. Although such genome-wide
microarray analysis has been valuable and has led to the
identification of several transcripts that are potentially
Independent ChIP assay demonstrates binding of p63 to ChIPed DNA sequences Figure 4
Independent ChIP assay demonstrates binding of p63 to ChIPed DNA sequences. ChIP was performed on HaCaT 
cells with N-terminal RR-14 and C-terminal H-129 anti-p63 antibodies. (A) Enrichment of target genes relative to IgG on an 
agarose gel. (B) Real-time PCR demonstrating the relative enrichment of p63 target genes with p63 antibodies and IgG. Primer 
sequences utilized are listed in Additional File 3B.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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turned on and off by p63, these experiments have several
limitations. First, it is difficult to ascertain whether a
responsive gene is a direct or an indirect target of p63. Sec-
ond, in experiments based on over expression of p63, it is
likely that the response of some genes is driven by the
exaggerated non-physiological concentration of this tran-
scription factor. Third, the selected cell types that have
often been utilized for these studies do not express endog-
enous p63 and thus may not represent the normal cellular
milieu under which p63 operates. Finally, such studies a
priori do not provide any information on the location of
the p63-responsive elements that control the expression
of target genes. Search for such regulatory elements is fur-
ther hampered by the degenerate nature of the p63 DNA-
binding sequence. Indeed, bioinformatics approaches
often identify an unrealistically large number of potential
p63 binding sites without distinguishing those that are
functionally relevant. Hence, despite the identification of
many p63 target genes, it has been difficult to ascertain
whether p63 is involved in direct regulation of those genes
by binding to their promoter and/or enhancer elements.
In contrast, here we have undertaken a direct approach of
ChIP in combination with sequencing and mapping of
EMSA demonstrates binding of ΔNp63 to p63 binding sites located within the ChIPed DNA sequences Figure 5
EMSA demonstrates binding of ΔNp63 to p63 binding sites located within the ChIPed DNA sequences. (A) 
EMSAs were performed by radiolabeling oligonucleotide probes containing p63 binding sites from the various ChIPed DNA 
sequences corresponding to known genes as indicated above each lane. Two radiolabeled oligonucleotide probes from each 
ChIPed sequence were each incubated with recombinant His-tagged ΔNp63α protein. Arrow indicates ΔNp63α. (B) EMSA 
was performed with nuclear extract from HaCaT cells and incubated with the radiolabeled oligonucleotide probe that bound 
best to recombinant protein demonstrated in A above. A complex containing ΔNp63 is supershifted with an anti-ΔNp63 anti-
body. See Additional File 1 for oligonucleotide sequences used in EMSA.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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isolated genomic DNAs to locate binding sites for ΔNp63
and its potential target genes in vivo. Indeed, such ChIP
strategies have been successfully utilized to not only deter-
mine whether a candidate genomic site is occupied by a
specific transcription factor but to also identify transcrip-
tion factor targets. However, in such cases it has been tech-
nically challenging to separate out the specific regulatory
DNA segment that is bound to the transcription factor
from the vast excess of non-specifically precipitated DNA.
To overcome these challenges, we have fine-tuned the
ChIP procedure and modified it to successfully identify in
vivo ΔNp63 target genes from HaCaT cells, which express
high levels of ΔNp63, the major isoform of p63 protein in
keratinocytes. First, since the immunoprecipitated DNA is
of limited amount, we utilized a ligation-mediated PCR
technique, in which the ChIP products were ligated to
linkers and amplified by PCR using the linker sequence.
This allowed us to obtain sufficient material for subse-
quent purification and cloning. Second, to eliminate non-
specific DNA fragments prior to cloning the ChIPed DNA,
we purified the PCR-amplified fragments by incubating
them with agarose beads containing GST-ΔNp63α. This
step ensures that fragments that contain DNA binding-
sites for ΔNp63 are selectively enriched and can be sepa-
rated from non-specific DNA. The potential caveats to
such a purification step are that some DNA fragments con-
taining genuine ΔNp63-targets might fail to bind to
recombinant GST-ΔNp63α or that non-specifically pre-
cipitated DNA fragments can fortuitously bind to GST-
ΔNp63α under the in vitro conditions of the assay. In
addition, genomic segments to which ΔNp63 are
recruited indirectly for example through protein-protein
interactions are likely to be under-represented in this
experimental scheme. However, our results suggest that
the benefits of utilizing such an enrichment step clearly
outweigh the potential drawbacks of the overwhelming
background of non-specific genomic immunoprecipitated
DNA.
ΔNp63α activates the ChIPed DNA sequences in reporter gene assays Figure 6
ΔNp63α activates the ChIPed DNA sequences in reporter gene assays. Luciferase constructs containing the various 
ChIPed DNA sequences cloned upstream of a heterologous TK promoter demonstrate high levels of activity when co-trans-
fected with an expression plasmid encoding ΔNp63α in PtK2 cells. Luciferase values were determined and normalized against 
β-galactosidase values. Corrected luciferase values for cells transfected with empty vector pCMV-HA were set at 1. TK; thymi-
dine kinaseBMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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One of the interesting findings that emerge from our stud-
ies is that the vast majority of these ΔNp63-binding sites
are not localized to the proximal promoters of the target
genes. This is in agreement with recent genome-wide tar-
get identification studies on other transcription factors
such as Sp1, p53 and Myc, which demonstrate that a
majority of the binding sites are not in the proximal pro-
moter but rather scattered[25]. Interestingly, a large subset
of the ΔNp63 targets were not close to any known gene;
these could represent potential long range enhancers or
unknown genes that have not been annotated or non-cod-
ing RNAs. Taken together, our study reinforces the need to
not limit examination of the proximal promoter region
only when searching for direct targets of transcription fac-
tors.
Our improved ChIP-based screening strategy allowed us
to identify a large number of ΔNp63-response elements
and their corresponding targets. Here we have examined a
subset of the ΔNp63 target genes in detail. Our data show
that the majority of the candidate target genes are co-
expressed with ΔNp63 in HaCaT cells and that the specific
segment isolated from the cloning of DNA immunopre-
cipitated is indeed occupied by ΔNp63 as determined by
independent ChIP experiments. We also demonstrate that
these segments harbor at least one p63 response element
that can bind to both recombinant ΔNp63 and ΔNp63
present in HaCaT nuclear extract and that these segments
can be transcriptionally activated by ΔNp63α in transient
transfection assays. Finally, reduction in the levels of
ΔNp63 in HaCaT cells led to significant decrease in tran-
script levels for a majority of the p63 target further validat-
ing the relevance of p63 in regulating these genes and
confirming that the eleven genes fulfill the criteria to be
direct transcriptional targets of p63. Only two genes,
MXD3 and B4GALT1 were de-repressed even though in
transient transfection experiments the DNA fragments
immunoprecipitated by ΔNp63 corresponding to both
MXD3 and B4GALT1 were positively activated. The fact
that the majority of the targets identified by our approach
are activated by ΔNp63 may reflect a bias towards selec-
tion of a high affinity p63-binding site due to the incorpo-
Expression of target genes is altered when p63 expression is knocked down by siRNA Figure 7
Expression of target genes is altered when p63 expression is knocked down by siRNA. HaCaT cells were trans-
fected with p63 siRNA. Expression of target genes was analyzed by Real-time PCR. Mock-transfected cells were used as a con-
trol. Primer sequences used are listed in Additional File 3A.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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ration of an additional purification step introduced in the
cloning procedure. However it is clear from numerous
studies that ΔNp63 also represses transcription (as evident
by our results for MXD3 and B4GALT1). This might poten-
tially be mediated through interaction of ΔNp63 with non
canonical response sites. Collectively, our data support
the growing consensus that the ΔNp63 isoform is prima-
rily involved in transcriptional activation of target genes
rather than merely acting as a dominant negative that
opposes the function of TAp63.
The diverse nature of the targets identified in our study
reinforces the notion that p63 plays a role in complex bio-
logical pathways that affect a wide variety of cellular proc-
esses. As a critical regulator of keratinocyte development
and differentiation, it is not difficult to imagine p63 as a
focal point in the transcriptional network and cascades.
This role of p63 as master regulator is supported by a large
number of potential targets identified in this study that
are transcription factors such as MXD3 and STAT6. Simi-
larly our identification of NOTCH2NL as a ΔNp63 target
gene contributes to the growing list of Notch family mem-
bers and effectors of this pathway that are regulated by
p63[19,26]. The p63 targets uncovered in our study
include genes previously linked to p63, such as DDR1.
Discoidin domain receptor 1 (DDR1) is a unique receptor
tyrosine kinase activated by various types of collagens and
is known to play a role in epithelial cell attachment,
migration, survival, and proliferation[27,28]. Upregula-
tion of DDR1 by p63 has been observed in several cases
by gain of function studies; our ChIP analysis now clearly
demonstrates that DDR1 is a direct transcriptional tar-
get[12,29]. What is also clear from surveying the list of
ΔNp63 targets is that there are predicted genes with
unknown functions. Regulation of these unknown genes
by ΔNp63 may be one underlying mechanism by which
p63 may mediate some of its myriad biological activity.
As this manuscript was in preparation, two independent
studies were published in which genome-wide p63 bind-
ing sites were determined by ChIP-Chip technology. In
the first study, the Mantovani group performed ChIP-on-
Chip experiments on HaCaT cells using two different plat-
forms; the 12K CpG islands and 12K promoter arrays that
led to the identification of ~200 target loci [30]. In the sec-
ond study, Yang et al utilized genome wide tiled microar-
rays covering the entire nonrepetitive human genome,
that lead to identification of ~5800 target sites for
p63[31]. These studies were performed in ME180 cervical
carcinoma cell line with the 4A4 anti-p63 antibody that
recognizes all p63 isoforms. A closer look at these data
and that of ours presented in this paper show that the data
sets generated from these studies display significant over-
lap but also distinct patterns. Indeed twenty-five percent
of the ΔNp63 target genes that we report in this work have
also been shown to be putative p63 target genes based on
these two studies (Table 1 and 3). The differences in the
data sets probably result from experimental noise associ-
ated with the ChIP-ChIP experiments, differences in cell
culture conditions such as cell type and/or proliferation
state and the distinct antibodies utilized in these studies.
The presence of different p63 isoforms and their unique
properties surely adds to this complexity.
An interesting point to be considered is that for many of
the p63 targets, it is likely that there are more than one
p63-response elements. These elements are thus scattered
in the proximal promoter, in the intragenic region and at
a distance far from both the 5' and 3' end of the gene itself.
Pertinent to this notion, we find a p63-response element
in the third intron of the DDR1 gene, whereas the data
from Yang et al., point to p63-response element located 5'
of the gene [31]. It is likely that both these sites are bona-
fide p63 binding sites. The presence of multiple p63-
response elements reflects the importance of p63 in regu-
lating DDR1 gene expression. This situation is similar to a
well-characterized p63 target, the K14 gene, where p63
binding sites are present both in the proximal promoter
and a distal enhancer[10]. Because each experimental
condition captures only a snapshot of the entire p63
directed transcriptome, it is important that additional
studies are performed to take into account the dynamic
cellular environment in which p63 operates. Our
approach described in this paper validates the use of ChIP
coupled with an enrichment strategy to identify transcrip-
tional targets in vivo and demonstrates the feasibility of
such an approach that can be applied on a large scale. The
various complementary strategies should provide a start-
ing point to dissect out the network of relevant p63 targets
and offer a strong basis for the elucidation of the gene reg-
ulatory pathways that are controlled by p63 in keratinoc-
ytes and other cell types.
Methods
Cell culture
HaCaT cells were maintained in DMEM supplemented
with 10% fetal bovine serum and 100 U/ml penicillin and
100  μg streptomycin. Cells were routinely passaged at
90% confluency. Ptk2 (rat kangaroo kidney epithelial)
cells were grown in minimal essential medium supple-
mented with 10% fetal bovine serum, 1% MEM non-
essential amino acid solution, 100 U/ml penicillin and
100 μg/ml streptomycin.
Chromatin Immunoprecipitation (ChIP) assays and 
cloning of immunoprecipitated products
Chromatin immunoprecipitation experiments were per-
formed using HaCaT cells with anti-p63 antibodies as
described previously[21]. To facilitate cloning immuno-
precipitated DNA was amplified by linker mediated PCR.BMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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Linker DNA consists of two annealed oligonucleotides: 5'-
AGAAGCTTGAATTCGAGCAGTCAG-3', phosphorylated
at the 5' end, and 5'-CTGCTCGAATTCAAGCTTCT-3', con-
taining a Hind III restriction enzyme site. Linkers were
ligated to the immunoprecipitated DNA with T4 DNA
ligase (Invitrogen) and amplification was carried out
directly, without purification of ligated DNA. Immuno-
precipitated DNA after amplification was diluted 1:2 with
DNA binding buffer (20 mM Tris pH 7.8, 50 mM NaCl, 1
mM MgCl2, 0.2 mM EDTA, 5% glycerol, 0.5 mM DTT, 0.5
mM PMSF) and incubated with Glutathione Sepharose 4B
beads (Amersham Biosciences) loaded with ΔNp63α for 2
hours to enrich for p63 binding sites. DNA was eluted
with buffer 1% SDS and 100 mM NaHCO3 and subse-
quently phenol-chloroform purified. Linker DNA was
removed by digestion with Hind III restriction enzyme
and purified with PCR purification kit (Qiagen) and
cloned into pBluescript. Clones were sequenced and ana-
lyzed in silico.
In silico data analysis
Clones were sequenced and a BLAST search of the human
genome database at NCBI was performed to identify
potential target genes. Genes located within 100 kb of the
ChIPed-DNA sequence were considered as potential p63
targets. In situations where two genes were located within
this range, the closest gene was chosen. In cases, where the
sequence was within equal distance of two genes, both
genes were chosen.
RT-PCR
Total RNA from HaCaT cells was isolated and purified by
TRizol (Invitrogen) according to established protocols.
Two μg of total RNA from HaCaT cells and human skin
(Stratagene) was reverse transcribed with the iScript cDNA
synthesis kit (Bio-Rad). The primers listed in Additional
File 3A were designed to span at least one intron. β-actin
was used as a control and a 425 bp fragment was ampli-
fied with specific primers 5'-GCTCACCATGGATGATGA-
TATCGC-3' and 5'-GATAGCATAGCCTGGATAGCAACG-
3'. Jump Start Taq Polymerase (Sigma-Aldrich) was used
for PCR amplifications.
Confirmation of p63 binding to target sequences by ChIP
Selected p63 target sites were evaluated for binding by p63
by independent ChIP assays utilizing immunoprecipi-
tated DNA from two different anti-p63 antibodies, H-129
(Santa Cruz) and RR-14 [10]. Primers utilized for ChIP
assays are listed in Additional File 3B. Real time PCR con-
ditions were similar to the one described for siRNA knock-
down of p63.
Preparation of recombinant p63, nuclear extracts and 
Electrophoretic Mobility Shift Assays (EMSAs)
HaCaT cells were grown as described above. Nuclear
extracts from HaCaT cells were prepared by standard
methods as described before[21]. The purification of His-
ΔNp63α protein was performed according to standard
protocols as described previously[13]. EMSAs were per-
formed with either 100 ng of recombinant proteins or 5
μg of nuclear extracts and end-labeled double-stranded
oligonucleotides as previously described[13]. Protein-
DNA complexes were resolved by gel electrophoresis on
5% non-denaturing polyacrylamide gels in 1 × TBE buffer
at room temperature. The gels were dried and visualized
by autoradiography after electrophoresis. Anti-p63 anti-
bodies used for supershift experiments have been
described before[21].
Plasmids
Recombinant plasmids were constructed using standard
molecular biology protocols. ChIPed-DNA sequences cor-
responding to NR3C1,  ZNRF2,  STAT6,  HSF2,
NOTCH2NL,  MXD3,  B4GALT1,  AHR,  YTHDF3, and
FBXO32 were PCR amplified and cloned into Kpn I – Nhe
I or KpnI – Spe I sites of the pGL3-basic vector (Promega)
containing the thymidine kinase (TK) minimal pro-
moter[10]. All constructs were verified by sequencing.
Transient transfections and reporter assays
Ptk2 cells were seeded in 6 well plates the day before
transfection. Transfections were performed using Fugene
6 reagent (Roche) according to the manufacturer's proto-
col. One μg of each luciferase reporter construct was trans-
fected per well along with 0.25 μg of pCMVLacZ plasmid
to serve as an internal control for transfection efficiency.
Reporter assays were performed as previously
described[21]. Means and standard deviations were calcu-
lated based on data from three independent transfection
experiments.
siRNA knockdown of p63
HaCaT cells were seeded 24 hours prior to transfection in
100 mm plates. Transfections were performed with cells at
30–40% confluency with SiGenome SMART pool Human
TP73L NM-003722 (Dharmacon) using Lipofectamine
2000 (Invitrogen). Cells were collected 48 and 60 hrs after
transfection and analyzed for knockdown of p63 by West-
ern blot analysis and quantitative PCR. For Western blot
analysis, cell extracts were prepared by resuspending the
pellets in Laemmli sample buffer (Bio-Rad). Approxi-
mately an equal amount of each sample was denatured at
96°C for 10 minutes. Blocking of the membrane was per-
formed with 5% non-fat dry milk diluted in 150 mM
NaCl, 10 mM Tris pH 7.5, and 0.1% Tween 20. Primary
rabbit anti-p63 (RR14) was used for detection of ΔNp63
protein levels and membrane was stripped and re-probedBMC Molecular Biology 2007, 8:43 http://www.biomedcentral.com/1471-2199/8/43
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with antibodies against β-tubulin to demonstrate equal
loading. For quantitative PCR, RNA was extracted from
siRNA-transfected and mock-transfected HaCaT cells and
subsequently reverse transcribed. Quantitative PCR was
performed with 2 μl of 1:5 diluted cDNA, 10 μM of each
primer and the suggested amount of SYBR Green I dye
(Bio-Rad) according to the manufacturer's instructions.
Cycling parameters were as follows: 95°C for 8 minutes
followed by 35 cycles at 95°C for 15 seconds and 60°C
for 1 minute. Fluorescent data were specified for collec-
tion during the 60°C step. Data were normalized to the
reference gene β-2-microglobulin. All reactions were
repeated at least three times in triplicates and the relative
expression level of each gene was determined.
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